Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor provides detailed technical information on the human health, environmental and value assessments of trifludimoxazin, Vulcarus and Voraxor.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and VoraxorHTMLEnglish publication HTML
-
Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and VoraxorHTMLFrench publication HTML
Similar records